Age-Associated Upregulation of Glutamate Transporters and Glutamine Synthetase in Senescent Astrocytes In Vitro and in the Mouse and Human Hippocampus
Carregando...
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Autores
MATIAS, Isadora
DINIZ, Luan Pereira
ARAUJO, Ana Paula Bergamo
DAMICO, Isabella Vivarini
MOURA, Pamella de
CABRAL-MIRANDA, Felipe
DINIZ, Fabiola
PARMEGGIANI, Belisa
COELHO, Valeria de Mello
Citação
ASN NEURO, v.15, article ID 17590914231157900, 13p, 2023
Resumo
Aging is marked by complex and progressive physiological changes, including in the glutamatergic system, that lead to a decline of brain function. Increased content of senescent cells in the brain, such as glial cells, has been reported to impact cognition both in animal models and human tissue during normal aging and in the context of neurodegenerative disease. Changes in the glutamatergic synaptic activity rely on the glutamate-glutamine cycle, in which astrocytes handle glutamate taken up from synapses and provide glutamine for neurons, thus maintaining excitatory neurotransmission. However, the mechanisms of glutamate homeostasis in brain aging are still poorly understood. Herein, we showed that mouse senescent astrocytes in vitro undergo upregulation of GLT-1, GLAST, and glutamine synthetase (GS), along with the increased enzymatic activity of GS and [H-3]-D-aspartate uptake. Furthermore, we observed higher levels of GS and increased [H-3]-D-aspartate uptake in the hippocampus of aged mice, although the activity of GS was similar between young and old mice. Analysis of a previously available RNAseq dataset of mice at different ages revealed upregulation of GLAST and GS mRNA levels in hippocampal astrocytes during aging. Corroborating these rodent data, we showed an increased number of GS + cells, and GS and GLT-1 levels/intensity in the hippocampus of elderly humans. Our data suggest that aged astrocytes undergo molecular and functional changes that control glutamate-glutamine homeostasis upon brain aging.
Palavras-chave
astrocyte, glutamate-glutamine cycle, GLT-1, aging, hippocampus, senescence
Referências
- Armada-Moreira A, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00090
- Bellaver B, 2017, MOL NEUROBIOL, V54, P2969, DOI 10.1007/s12035-016-9880-8
- Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069
- Busanello ENB, 2014, J NEUROL SCI, V346, P260, DOI 10.1016/j.jns.2014.09.003
- Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
- Cheung G, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28331-7
- Chinta SJ, 2018, CELL REP, V22, P930, DOI 10.1016/j.celrep.2017.12.092
- Chung EKY, 2008, J COMP NEUROL, V511, P421, DOI 10.1002/cne.21852
- Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115
- Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8
- DANH HC, 1985, GERONTOLOGY, V31, P95, DOI 10.1159/000212686
- Diniz LP, 2020, NEUROCHEM INT, V138, DOI 10.1016/j.neuint.2020.104758
- Diniz LP, 2019, MOL NEUROBIOL, V56, P4653, DOI 10.1007/s12035-018-1396-y
- Diniz LP, 2014, NEUROCHEM INT, V78, P18, DOI 10.1016/j.neuint.2014.07.008
- Ferrarese C, 2001, NEUROL SCI, V22, P65, DOI 10.1007/s100720170049
- Gao P, 2019, EXP GERONTOL, V118, P9, DOI 10.1016/j.exger.2018.12.018
- Gasiorowska A, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.654931
- Guerrero A, 2021, TRENDS NEUROSCI, V44, P714, DOI 10.1016/j.tins.2021.06.007
- Hoshi A, 2018, NEUROPATH APPL NEURO, V44, P628, DOI 10.1111/nan.12475
- Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97
- Kubrusly RCC, 2018, NEUROCHEM INT, V112, P27, DOI 10.1016/j.neuint.2017.10.016
- Kulijewicz-Nawrot M, 2013, ASN NEURO, V5, P273, DOI 10.1042/AN20130017
- Lee EB, 2022, NATURE AGING, V2, P726, DOI 10.1038/s43587-022-00257-1
- Limbad C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227887
- Limon ID, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.578922
- Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
- LOWRY OH, 1951, J BIOL CHEM, V193, P265
- Mahmoud S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020184
- Matias I, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00059
- McKenna Mary C, 2013, Front Endocrinol (Lausanne), V4, P191, DOI 10.3389/fendo.2013.00191
- Minet R, 1997, CLIN CHIM ACTA, V268, P121, DOI 10.1016/S0009-8981(97)00173-3
- NAJLERAHIM A, 1990, NEUROBIOL AGING, V11, P155, DOI 10.1016/0197-4580(90)90049-6
- Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009
- Olabarria M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-55
- Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x
- Potier B, 2010, AGING CELL, V9, P722, DOI 10.1111/j.1474-9726.2010.00593.x
- Roalf DR, 2020, NEUROBIOL AGING, V95, P240, DOI 10.1016/j.neurobiolaging.2020.07.015
- Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x
- SARANSAARI P, 1995, MECH AGEING DEV, V81, P61, DOI 10.1016/0047-6374(95)01583-L
- Segovia G, 2001, NEUROCHEM RES, V26, P37, DOI 10.1023/A:1007624531077
- Shimabukuro MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23795
- Sonnewald U, 2016, ADV NEUROBIOL, V13, P1, DOI 10.1007/978-3-319-45096-4_1
- Tani H, 2014, NEURON, V81, P888, DOI 10.1016/j.neuron.2013.12.026
- Todd AC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249607
- Vatassery GT, 1998, NEUROCHEM RES, V23, P121, DOI 10.1023/A:1022495804817
- Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016
- WHEELER DD, 1986, EXP GERONTOL, V21, P159, DOI 10.1016/0531-5565(86)90069-0
- Wruck W, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00907-8
- Yeoman M, 2012, NAT REV NEUROSCI, V13, P435, DOI 10.1038/nrn3230
- Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013
- Zhang YL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.454